Similar to our study, Ohri et al. performed a study on macrophage distribution in non small cell lung cancer (NSCLC) using, among others, NOS2 as a M1 marker, where the presence of NOS2+ macrophages in tumor islets, but not tumor stroma, was associated with an improved prognosis [54]. This evidence concerns the gene NOS2 and neoplasm.